Position in NXL
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$7,953
-$433 QoQ
Shares Held
803
0.0% QoQ
Ownership
0.109%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#9
of 20 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NXL Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026NORTHERN TRUST CORP holds $6,680,314,817 across 109 Medical Devices names. NXL ranks #108 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
18,273,301 | $1,658,119,329 | |
| 2 | SYK |
Stryker Corp
|
3,326,549 | $1,047,330,681 | |
| 3 | MDT |
Medtronic plc
|
11,626,741 | $909,559,945 | |
| 4 | BSX |
Boston Scientific Corp
|
12,964,638 | $553,330,745 | |
| 5 | EW |
Edwards Lifesciences Corp
|
5,671,229 | $513,019,370 | |
| 6 | GEHC |
GE HealthCare Technologies Inc.
|
3,938,748 | $252,119,255 | |
| 7 | DXCM |
Dexcom Inc
|
3,295,144 | $221,927,945 | |
| 8 | STE |
STERIS plc
|
925,623 | $194,908,431 |
All Filings in NXL
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,953 | 24,100 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $8,386 | 24,100 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $13,447 | 24,100 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $22,099 | 24,100 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $23,810 | 24,100 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $46,995 | 24,100 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $36,075 | 13,071 | Shares | Defined | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||